Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-20
    E.g., 2018-10-20

Archive Search

3 results
12:00 AM, Jun 21, 2010  |  BC Week In Review | Company News  |  Deals

Affomix, University of Montreal Pharmacogenomics Centre, Montreal Heart Institute deal

The parties will discover and produce biomarkers for use in cardiovascular diagnostics. Affomix will contribute its …
reagents for proteomic profiling of specific cardiovascular targets. Further details were not disclosed. Affomix Corp …
12:00 AM, Jan 25, 2010  |  BC Week In Review | Company News  |  Deals

Affomix, City of Hope National Medical Center deal

Affomix will use its Y2Hexpress and Phage ESCape technologies to develop antibodies for City of Hope …
cancers, including renal and prostate, for use in its laboratories. Financial terms were not disclosed. Affomix
12:00 AM, Jan 11, 2010  |  BC Week In Review | Company News  |  Deals

Affomix, KalGene deal

Affomix will use its Y2HExpress technology to generate antibodies against undisclosed targets from Kalgene for potential …
diagnostic and therapeutic use in breast cancer. Affomix will receive an upfront payment and is eligible …
for milestones. Further terms were not disclosed. Affomix Corp. , Branford, Conn.   KalGene Pharmaceuticals Inc …